Clinical Utility of ctDNA Analysis in Lung Cancer—A Review
Circulating free DNA (cfDNA) is genetic material released from various cells into bodily fluids. Among its fractions, circulating tumor DNA (ctDNA) originates from tumor cells and reflects their genetic material, including mutations and epigenetic changes. Methods commonly employed for detecting ctD...
Saved in:
| Main Authors: | Kamil Makar, Agata Wróbel, Adam Antczak, Damian Tworek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Advances in Respiratory Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2543-6031/93/3/17 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methylated ARHGAP40 DNA as a potential biomarker for early diagnosis in high-grade ovarian serous cancer
by: Jiaxin Chai, et al.
Published: (2025-07-01) -
Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring
by: Alessandro Mannucci, et al.
Published: (2024-11-01) -
Cerebrospinal fluid Circulating Tumor DNA (ctDNA) as a biomarker for CNS metastases in Non-Small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis comparing CSF ctDNA and traditional methods
by: Oluwatobi O. Olayode, et al.
Published: (2025-07-01) -
Imaging and outcome correlates of ctDNA methylation markers in prostate cancer: a comparative, cross-sectional [⁶⁸Ga]Ga-PSMA-11 PET/CT study
by: Kilian Kluge, et al.
Published: (2025-02-01) -
Evaluation of Bridge Capture technology for mutation profiling in liquid biopsies of metastatic colorectal cancer patients
by: Aparna Ganesan, et al.
Published: (2025-07-01)